Table 4.

Ratio of long-term family costs to healthcare providers costs for England, Ireland, Italy and Spain

Ratio of long-term family costs to healthcare providers costs (€; 2020)
England	Almost 16 times more than monotherapy with carbamazepine (27,627)	18 times more than adjunctive therapy - Gabapentin (24,100) Almost 18 times more than adjunctive therapy -Oxcarbazepine (25,218) (potentially the most cost-effective)
Ireland	Almost 46 times more than monotherapy with carbamazepine (9,658)	Almost 62 times more than adjunctive therapy - Gabapentin (7,128)
Italy	Almost 66 times more than monotherapy with carbamazepine (6,690)	82 times more than adjunctive therapy - Gabapentin (5,381)
Spain	Almost 60 times more than monotherapy with carbamazepine (7,377)	Almost 66 times more than adjunctive therapy -Oxcarbazepine (6,721)

Note: Ratio of long-term family costs to healthcare providers costs based on scenario 3 (15-year-time frame =€441,505).